Filter
725
Text search:
General
Pharmaceutical
Council
Featured
Recommendations
52
New Publications
196
Language
Document type
No document type
405
Studies & Reports
140
Guidelines
88
Strategic & Response Plan
38
Manuals
23
Training Material
12
Fact sheets
9
Situation Updates
7
Resource Platforms
2
Brochures
1
Countries / Regions
India
46
Kenya
34
South Africa
30
Nigeria
26
Ethiopia
24
Western and Central Europe
20
Tanzania
17
Uganda
16
Global
16
Ghana
15
Zimbabwe
15
Nepal
15
Zambia
15
Sierra Leone
13
Rwanda
12
Ukraine
11
Namibia
10
Bangladesh
9
Lesotho
8
Eastern Europe
8
Liberia
7
Philippines
7
Malawi
7
Africa
7
Syria
6
Eswatini/ Swaziland
6
Indonesia
5
Botswana
5
Myanmar / Burma
5
South–East Asia Region
4
Latin America and the Carribbean
4
Eastern Europe and Central Asia
4
Pakistan
3
Cambodia
3
United Kingdom
3
Guinea
2
Burkina Faso
2
Congo, Democratic Republic of
2
Cameroon
2
Haiti
2
Germany
2
Egypt
2
Thailand
2
Mozambique
2
Sudan
2
Brazil
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Asia
2
Fiji
2
Albania
2
Moldova
2
Jamaica
2
Mali
1
USA
1
Saudi Arabia
1
Niger
1
South Sudan
1
Jordan
1
Lebanon
1
Chad
1
China
1
Ireland
1
Benin
1
Central African Republic
1
Peru
1
El Salvador
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Russia
1
Bulgaria
1
Romania
1
Lithuania
1
Iran
1
Australia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
360
Clinical Guidelines
37
Public Health
32
Key Resources
18
Pharmacy & Technologies
9
Women & Child Health
7
Capacity Building
5
Toolboxes
AMR
72
Pharmacy
70
COVID-19
53
Mental Health
47
HIV
38
TB
25
Caregiver
19
Conflict
17
Global Health Education
17
NCDs
14
Rapid Response
11
Health Financing Toolbox
11
Planetary Health
10
Ebola
8
Specific Hazards
8
NTDs
6
Polio
4
Refugee
4
Disability
2
Natural Hazards
2
Cholera
1
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effec
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property fo
...
"The Emergency Response Guidelines for Anhydrous Hydrogen Fluoride (Guidelines) were prepared
by the American Chemistry Council’s (ACC) Hydrogen Fluoride Panel (Panel). This document is
intended to provide
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne
...
These guidelines have been developed specifically to address ethical issues of conducting research in children.
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis
...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand
...
Contains: Application formal for ICMR Junior Research Fellowship Programme (for ICMR- Junior Research Fellow); 1st /2nd /3rd /4th Annual Report of the work done during the fellowship; Indian Council of Medical Research Fellowship Rules.
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
recommended
The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has informed policymaking in the UK and other countries i
...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o
...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and re
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to m
...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca
...
